Sarah Faircliffe
Sarah Faircliffe
I work as a Legal Director in London. As a member of our International Life Sciences Group, I specialise in European regulatory law concerning medicinal products, medical devices and related areas. Bringing a wealth of industry and policy knowledge to my role here at Bird & Bird, I offer unique insight into the law and procedures concerning the regulation of medicines, having spent 10 years as Legal Adviser with the European Medicines Agency (EMA). During my time at the EMA, I advised on many areas, including orphan drugs, paediatrics and generics of centrally authorised products, as well as advising the EMA's scientific committees on legal issues.
10
Articles
0
Comments
EU Parliament Adopts Position on Pharmaceutical Reform: Focus on Combating Antimicrobial Resistance
On April 10, 2024, the European Parliament voted to adopt a revised version of the European Commission’s...
June 18, 2024
4 min read
Reforming the European pharmaceutical legislation: Shortages of medicinal products
This article is part of a series that covers the proposed reforms to EU pharmaceutical legislation....
August 7, 2023
5 min read
What does the European Commission’s proposed reform of EU pharmaceutical legislation mean for Paediatric medicines?
This article is part of a series that covers the proposed reforms to EU pharmaceutical...
July 26, 2023
4 min read
Reform of the EU pharmaceutical legislation: proposals to fight against antimicrobial resistance
This article is part of a series that covers the proposed reforms to EU pharmaceutical legislation....
July 10, 2023
4 min read
Proposed reform of the EU pharmaceutical legislation: New regime for orphan medicinal products under the proposed regulation
This article is part of a series that covers the proposed reforms to EU pharmaceutical legislation....
June 27, 2023
4 min read
Strengthened Environmental Risk Assessment requirements under the proposed new directive on medicinal products for human use
This article is part of a series that covers the proposed reforms to EU pharmaceutical legislation....
June 23, 2023
3 min read
European Commission proposes to change the rules on regulatory data protection for medicines
This article is part of a series that covers the proposed reforms to EU pharmaceutical legislation....
June 15, 2023
4 min read
Post-Transition Brexit: New MHRA Guidelines on Medicines
With a post-transition Brexit looming on the horizon, the Medicines and Healthcare products Regulatory...
September 30, 2020
7 min read
Post-Transition Brexit: New MHRA Guidelines on Medical Devices
With a post-transition Brexit looming on the horizon, the Medicines and Healthcare products Regulatory...
September 21, 2020
4 min read
COVID-19: UK Public Health Perspectives
As Novel Coronavirus (COVID-19) continues to spread across the globe, in an effort to prepare for all...
March 27, 2020
13 min read